tiprankstipranks
Trending News
More News >
Merck announces FDA approval of enflonsia for prevention of RSV
PremiumThe FlyMerck announces FDA approval of enflonsia for prevention of RSV
1d ago
Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
Premium
The Fly
Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
2d ago
Merck announces topline results from Phase 3 CORALreef trials
Premium
The Fly
Merck announces topline results from Phase 3 CORALreef trials
2d ago
Merck granted review of Halozyme patent claims by PTAB
PremiumThe FlyMerck granted review of Halozyme patent claims by PTAB
8d ago
Merck & Company: Hold Rating Amid Short-Term Challenges and Strategic Uncertainties
Premium
Ratings
Merck & Company: Hold Rating Amid Short-Term Challenges and Strategic Uncertainties
8d ago
Merck & Co.: Strong Buy Rating Backed by Promising Oncology Pipeline and Strategic Initiatives
Premium
Ratings
Merck & Co.: Strong Buy Rating Backed by Promising Oncology Pipeline and Strategic Initiatives
8d ago
Merck announces data from trial studying KEYTRUDA plus Trodelvy
PremiumThe FlyMerck announces data from trial studying KEYTRUDA plus Trodelvy
9d ago
Merck announces safety, efficacy results from Phase 1 KANDLELIT-001 study
Premium
The Fly
Merck announces safety, efficacy results from Phase 1 KANDLELIT-001 study
12d ago
Merck announces results from dose confirmation part of Phase 2/3 waveLINE-003
Premium
The Fly
Merck announces results from dose confirmation part of Phase 2/3 waveLINE-003
12d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100